Quinupristin/dalfopristin
This code is not in the latest file (4Q26). It was last listed in 1Q23.
Payment limit per 500 MG, by effective quarter, 1Q21 to 1Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.This code is not in the latest file (4Q26). It was last listed in 1Q23.
Payment limit per 500 MG, by effective quarter, 1Q21 to 1Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.No NDCs mapped to this code in the 4Q26 crosswalk.
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 1Q23 | $493.97 | $0.00 | 500 MG | Quinupristin/dalfopristin | v1, posted December 6, 2023 |
| 4Q22 | $493.97 | +$156.505 | 500 MG | Quinupristin/dalfopristin | v1, posted June 22, 2023 |
| 3Q22 | $337.465 | −$90.863 | 500 MG | Quinupristin/dalfopristin | v1, posted June 9, 2023 |
| 2Q22 | $428.328 | +$0.136 | 500 MG | Quinupristin/dalfopristin | v1, posted December 14, 2022 |
| 1Q22 | $428.192 | −$16.48 | 500 MG | Quinupristin/dalfopristin | v1, posted June 8, 2022 |
| 4Q21 | $444.672 | −$12.207 | 500 MG | Quinupristin/dalfopristin | v1, posted June 2, 2022 |
| 3Q21 | $456.879 | −$2.162 | 500 MG | Quinupristin/dalfopristin | v1, posted June 2, 2022 |
| 2Q21 | $459.041 | +$0.211 | 500 MG | Quinupristin/dalfopristin | v1, posted March 1, 2022 |
| 1Q21 | $458.83 | – | 500 MG | Quinupristin/dalfopristin | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.